Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

Neoplasm Metastasis, Neoplasms

Non-squamous Non-small Cell Lung Cancer

Biliary Tract Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Carcinoma, Non-Small-Cell Lung

EGFR Positive Non-small Cell Lung Cancer

Glioma, Neoplasms

Carcinoma, Non-Small-Cell Lung

Relapsed Pediatric Solid Tumor

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Diffuse Intrinsic Pontine Glioma

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

Metastatic Pancreatic Adenocarcinoma

Drug-Related Side Effects and Adverse Reactions

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Neoplasms

Neoplasms, Recurrence

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Gastrointestinal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Advanced Stage Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma of Lung

Pancreatic Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Familial ependymoma, Astrocytoma, Medulloblastoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers

ROME

BRISK

BEVERLY

Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

ERLO-XIB

Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations

AvaTa

Efficacy and Safety of Precision Therapy in Refractory Tumor

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

ANSWER

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI

Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

EMERGING

BIOMEDE

BRILLIANT

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

ML22774

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

TREND

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

SEED

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy

GITIC

RT Plus EGFR-TKI for Wild-type NSCLC

TCL-1

Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma

Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC

Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer

CURCUMIN

NSCLC EGFR TKI

Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-)

Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma

The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib

Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC

TRACTS

A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma

Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer

Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Oncology

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Erlotinib in Treating Patients With Barrett Esophagus

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer